Compounds for the treatment of hepatitis C

US7541353B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Robert G. Gentles · Killingworth, US
• Xiaofan Zheng · Cheshire, US
• Min Ding · Dobbs Ferry, US
• Yong Tu · Cheshire, US
• Ying Han · Cheshire, US
• Piyasena Hewawasam · Middletown, US
• John F. Kadow · Wallingford, US
• John A. Bender · Middletown, US
• Kap-Sun Yeung · Madison, US
• Katharine A. Grant-Young · Madison, US
• Thomas W. Hudyma · Durham, US

Key dates

• Filing date: Mar 11, 2008
• Grant date: Jun 2, 2009
• Expiry date: Mar 11, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.